Free Trial

Vanguard Group Inc. Grows Position in Exponent, Inc. (NASDAQ:EXPO)

Exponent logo with Business Services background

Vanguard Group Inc. grew its position in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 1.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,345,503 shares of the business services provider's stock after acquiring an additional 67,296 shares during the period. Vanguard Group Inc. owned about 10.53% of Exponent worth $476,284,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. FMR LLC boosted its holdings in Exponent by 48.4% in the 3rd quarter. FMR LLC now owns 10,278 shares of the business services provider's stock valued at $1,185,000 after purchasing an additional 3,351 shares in the last quarter. PEAK6 Investments LLC purchased a new stake in shares of Exponent in the third quarter valued at approximately $271,000. Walleye Capital LLC purchased a new stake in shares of Exponent in the third quarter valued at approximately $288,000. Petrus Trust Company LTA acquired a new position in Exponent during the third quarter worth $709,000. Finally, Quarry LP raised its position in Exponent by 127.9% in the third quarter. Quarry LP now owns 604 shares of the business services provider's stock worth $70,000 after acquiring an additional 339 shares in the last quarter. 92.37% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Exponent

In other Exponent news, VP Richard Reiss sold 1,736 shares of the company's stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total value of $149,174.48. Following the sale, the vice president now owns 1,800 shares of the company's stock, valued at approximately $154,674. This represents a 49.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 2.10% of the stock is currently owned by company insiders.

Exponent Price Performance

Shares of NASDAQ EXPO traded down $1.46 during trading on Friday, hitting $77.06. 763,027 shares of the company were exchanged, compared to its average volume of 236,070. Exponent, Inc. has a 1 year low of $76.18 and a 1 year high of $115.75. The company has a market cap of $3.92 billion, a price-to-earnings ratio of 36.35 and a beta of 0.84. The firm's fifty day moving average price is $85.49 and its 200 day moving average price is $94.66.

Exponent (NASDAQ:EXPO - Get Free Report) last issued its earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same quarter last year, the company earned $0.41 EPS. On average, research analysts forecast that Exponent, Inc. will post 1.98 earnings per share for the current year.

Exponent Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Recommended Stories

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines